Enjoy complimentary customisation on priority with our Enterprise License!
The amlodipine besylate market size is forecast to increase by USD 196.4 million at a CAGR of 3.3% between 2023 and 2028. The market is experiencing significant growth due to the rising incidence of hypertension and the increasing usage of amlodipine besylate in various treatments. This calcium channel blocker is widely used to manage hypertension and angina pectoris. Its mechanism of action involves relaxing the smooth muscles in blood vessels, leading to a decrease in peripheral resistance and a reduction in blood pressure. Amlodipine besylate is available in various dosage forms, including oral tablets and oral solutions, catering to the diverse needs of healthcare providers and patients. Notable brands in the market include Katerzia, Norliqva, and Norvasc. Common side effects include gastrointestinal symptoms, dizziness, and decreased blood pressure. Despite its benefits, the use of amlodipine besylate may have side effects on human health, such as headaches, dizziness, and peripheral edema. These factors are shaping the dynamics of the market.
This medication acts by inhibiting the influx of calcium ions into the myocardial and smooth muscle cells, leading to the relaxation of blood vessels and decreased peripheral resistance. Healthcare providers may prescribe amlodipine besylate in several dosage forms to cater to diverse patient needs. These include oral tablets, oral solutions, and oral suspensions. The choice of dosage form depends on factors such as patient preference, age, and specific medical conditions. Some brand names for amlodipine besylate include Katerzia, Norliqva, and Norvasc. Regardless of the brand, the mechanism of action remains the same. When administered, amlodipine besylate should be stored at room temperature, away from direct sunlight and moisture. Proper storage ensures the medication's efficacy and safety. Common side effects of amlodipine besylate include stomach pain, nausea, tiredness, insomnia, edema, dizziness, and flushing.
Moreover, decreased blood pressure or hypotension can also occur, especially during the initial stages of treatment. Patients with conditions such as aortic stenosis, angina, heart attack, or allergies to amlodipine benzoate or other calcium channel blockers should consult their healthcare provider before using amlodipine besylate. It is essential to note that amlodipine besylate is a prescription medication and should not be used interchangeably with over-the-counter (OTC) medicines. Always follow the instructions provided by your healthcare provider regarding dosage, administration, and potential interactions with other medications. Side effects may vary in severity and frequency, and not all patients will experience them. If you experience any adverse reactions or worsening of symptoms, contact your healthcare provider immediately. In conclusion, amlodipine besylate is a calcium channel blocker used in the treatment of various cardiovascular conditions. It is available in several dosage forms, and proper storage is essential. Always consult your healthcare provider for proper usage and potential interactions with other medications.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The high blood pressure segment is estimated to witness significant growth during the forecast period. Amlodipine besylate is a vital medication used in healthcare to manage high blood pressure, a condition that can potentially harm the brain, heart, kidneys, and blood vessels if left untreated. This condition often goes unnoticed as many individuals may not experience symptoms until complications arise. Amlodipine functions by relaxing the muscles in the walls of blood vessels, improving blood flow and reducing the pressure on the arterial walls.
Get a glance at the market share of various segments Download the PDF Sample
The high blood pressure segment was the largest segment and valued at USD 728.30 million in 2018. This medication is available in various dosage forms, including oral tablets and oral solutions, under brand names such as Katerzia, Norliqva, Norvasc, among others. Patients are often required to continue taking amlodipine for an extended period to prevent angina (chest pain) and related heart issues. It is crucial for high blood pressure patients to adhere to their treatment regimen, even when feeling well, to mitigate potential health risks.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 52% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The Amlodipine Besylate market in North America is experiencing significant growth due to the high prevalence of hypertension and associated conditions such as aortic stenosis, angina, and heart attack in the region. The United States, in particular, is a major contributor to the market's expansion, given its large population and high healthcare expenditure. The country's dominance can be attributed to its substantial investment in the pharmaceutical industry, the presence of key players, and the high prevalence rate of heart failure cases. Moreover, the economic burden of these conditions is substantial, further fueling the demand for effective treatments like Amlodipine Besylate.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Rising incidence of hypertension is notably driving market growth. The global market for amlodipine besylate, a calcium channel blocker used primarily to manage blood pressure and chest pain associated with coronary artery disease, is experiencing significant growth due to the rising prevalence of hypertension and coronary artery disease worldwide.
Additionally, lifestyle factors such as alcohol consumption, tobacco use, and unhealthy diets are contributing to the rise in hypertension cases, further fueling market growth. It is essential to note that while prescription medicines like amlodipine besylate are crucial for managing these conditions, the availability of guidelines for their implementation and skilled personnel to carry out the recommendations are also vital factors in effective treatment. Thus, such factors are driving the growth of the market during the forecast period.
Increasing usage of amlodipine besylate in various treatments is the key trend in the market. Amlodipine Besylate is a medication primarily used for managing conditions such as hypertension, angina, and coronary heart disease. In certain cases of congestive heart failure, it may also be prescribed. Notably, it enhances oxygen delivery to angina patients with vasospastic symptoms. Amlodipine Besylate falls under the category of calcium channel blockers, which inhibit calcium influx into the myocardium and vascular smooth muscle during depolarization, leading to coronary vasodilation and relaxation of coronary smooth muscle.
This medication plays a crucial role in preventing angina attacks, improving exercise capacity, and reducing their frequency in patients with high blood pressure. Additionally, a treatment program incorporating a healthy diet, exercise, and, in some cases, medication like Amlodipine Besylate, is often recommended for individuals with heart conditions. Thus, such trends will shape the growth of the market during the forecast period.
Side effects on human health is the major challenge that affects the growth of the market. Amlodipine besylate, a calcium channel blocker available in tablet form, is used to manage conditions such as angina (chest pain) and hypertension (high blood pressure). However, this medication may cause adverse reactions in some individuals, including hives, allergic responses, swelling of the face, lips, tongue, and throat, pain in the jaw and shoulders, chest pain, nausea, and sweating.
Severe symptoms like pounding heartbeats and chest flutters, worsening chest pain, swelling of the feet and ankles, and extreme drowsiness or a feeling of fainting warrant immediate medical attention. These side effects may restrict the expansion of the market for amlodipine besylate during the forecast period. Hence, the above factors will impede the growth of the market during the forecast period
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Amsal Chem Pvt. Ltd: The company offers amlodipine besylate used for hypertensive and anginal condition.
The market research and growth report also includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Amlodipine besylate is a calcium channel blocker used to manage various cardiovascular conditions, including angina, aortic stenosis, and hypertension. It functions by relaxing the smooth muscles in blood vessels, improving blood flow and reducing the workload on the heart. This medication is available in various dosage forms, including oral tablets and oral solutions, for healthcare providers to prescribe based on individual patient needs. Patients should store amlodipine besylate at room temperature, away from direct sunlight and moisture. Common side effects include stomach pain, nausea, tiredness, sleepiness, edema, dizziness, and flushing. Severe side effects include decreased blood pressure, hypotension, irregular heartbeat, pounding heartbeats, muscle stiffness, allergic reactions, and symptoms of congestive heart failure. It's essential to follow the prescribed dosage and consult a healthcare provider if experiencing side effects. Amlodipine besylate should not be taken with over-the-counter (OTC) medicines, vitamins, calcium channel blockers, or alcohol without consulting a healthcare provider. Patients with liver disease, allergies, or a treatment program should inform their healthcare provider before using this medication. Conditions such as heart attack, stroke, chest pain, coronary artery disease, and hypertension can be managed with amlodipine besylate. Consult a healthcare provider for proper diagnosis and treatment. In case of an emergency, seek medical help immediately.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
129 |
|
Base year |
2023 |
|
Historic period |
2018 - 2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 3.3% |
|
Market growth 2024-2028 |
USD 196.4 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
3.1 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 52% |
|
Key countries |
US, Germany, UK, Canada, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Amsal Chem Pvt. Ltd., Apotex Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Century Pharmaceuticals Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Chartwell Pharmaceuticals LLC, Cipla Inc., Dr Reddys Laboratories Ltd., Lupin Ltd., MOEHS IBERICA SL, Orbion Pharmaceuticals Pvt. Ltd., Pfizer Inc., Rakshit Drugs Pvt. Ltd., Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., Synthon International Holding BV, Teva Pharmaceutical Industries Ltd., VPL Chemicals Pvt. Ltd., and Zydus Lifesciences Ltd. |
|
Market dynamics |
Parent market analysis, market report , market forecast , Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
